Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammatory mediators in epidermal tissue are a diverse group of molecules produced by skin cells—primarily keratinocytes—and resident or recruited immune cells. These mediators play crucial roles in initiating, propagating, and resolving inflammation within the skin. They include cytokines, chemokines, eicosanoids (such as prostaglandins and leukotrienes), vasoactive amines, peptides, acute-phase proteins, and antimicrobial peptides (AMPs). Dysregulation can lead to chronic inflammatory diseases such as psoriasis or eczema due to imbalanced production between pro-inflammatory and anti-inflammatory factors.
Various, including receptor antagonism, enzyme inhibition, and modulation of intracellular signaling pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammatory Mediators in Epidermal Tissue.